# Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program

> **NCT05793645** · NA · UNKNOWN · sponsor: **Air Liquide Santé International** · enrollment: 60 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** personalized care plan

## Key facts

- **NCT ID:** NCT05793645
- **Lead sponsor:** Air Liquide Santé International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-15
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05793645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05793645, "Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05793645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
